MagForce publishes 2013 interim report

01-Oct-2013 - MagForce AG published its figures for the first half of 2013, which ended on June 30, 2013. Chairman of the Management Board Ben J. Lipps commented: “The key event in the first half of 2013 was the successful capital increase in March of this year, which enabled the new glioblastoma study to go ...

MagForce publishes financial results and operative highlights for 2012

28-Jun-2013 - MagForce AG published its financial results and operative highlights for the fiscal year ending on December 31, 2012. The highlight of the Company’s development in the 2012 reporting period was the completion of the strategic realignment and operational restructuring of MagForce AG. Ultimately, ...

MagForce starts research project with University of Bremen

04-Feb-2013 - MagForce AG announced the start of a research project with the University of Bremen, Center for Environmental Research and Sustainable Technology, for the development of magnetic iron oxid particles with improved efficiency. The novel particles will allow a more efficient treatment of abdominal ...

MagForce to radically enforce market set up strategy with new management team

Core functions will be centralized in Munich

04-Oct-2012 - MagForce AG announced additions to the management board and further measures to enforce commercialization of NanoTherm® therapy. Thus, focussing on establishing the NanoTherm® therapy in the oncology market as well as on its commercialization for near-term value generation.In the short to mid ...

MagForce AG: Dr. Jan zur Hausen elected to the Supervisory Board of MagForce AG

21-Aug-2012 - MagForce AG announced that Dr. Jan zur Hausen was unanimously elected to the company's Supervisory Board at the Annual General Meeting. He is taking over from Dr. Stefan Elßer, who resigned effective as of the end of the Annual General Meeting.Dr. Jan zur Hausen (born in 1965) is a managing ...

MagForce AG Announces Changes to Supervisory and Management Boards

03-Nov-2011 - MagForce AG announced the resignation of Prof. Dr. Walter Rust as chairman of the Supervisory Board as of October 25, 2011 due to health reasons. Effective October 28, 2011, Dr. Peter Heinrich stepped down from his position as MagForce CEO and is expected, at a future date, to return to his ...

MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm Therapy

12-Oct-2011 - MagForce AG announced the treatment of a recurrent glioblastoma patient with the company's NanoTherm® therapy. The first part of the therapy (instillation of the nanoparticles) was carried out at the University Giessen and subsequent steps (nanoparticle activation and the accompanying ...

MagForce Selected as Winner of 2010 STEP Award in the Category Product/Technology

Prize awarded in recognition of company's innovation and growth potential

22-Nov-2010 - MagForce Nanotechnologies AG announced that it has been selected as the 2010 recipient of the STEP award in the category product/technology. The business award, initiated by Infraserv Höchst and F.A.Z. Institute along with industry sponsors, was awarded for the fifth time this year. "We are ...

MagForce Nanotechnologies AG Announces Management Team Expansion

18-Nov-2010 - MagForce Nanotechnologies AG announced the expansion of its management team. The new positions, Director of Intellectual Property, Director of Business/Corporate Development, Director of Finance & Controlling, and Director of Investor Relations & Corporate Communications, will support both the ...